BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34172003)

  • 1. Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study.
    MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
    BMC Infect Dis; 2021 Jun; 21(1):606. PubMed ID: 34172003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
    MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    MacKinnon MC; McEwen SA; Pearl DL; Parfitt EC; Pasquill K; Steele L; Laupland KB
    Epidemiol Infect; 2021 Aug; 149():e195. PubMed ID: 34353396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
    Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
    Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
    Lin WP; Huang YS; Wang JT; Chen YC; Chang SC
    BMC Infect Dis; 2019 Mar; 19(1):245. PubMed ID: 30866828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.
    de Kraker ME; Davey PG; Grundmann H;
    PLoS Med; 2011 Oct; 8(10):e1001104. PubMed ID: 22022233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London.
    Blandy O; Honeyford K; Gharbi M; Thomas A; Ramzan F; Ellington MJ; Hope R; Holmes AH; Johnson AP; Aylin P; Woodford N; Sriskandan S
    J Hosp Infect; 2019 Feb; 101(2):120-128. PubMed ID: 30403958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planning to halve Gram-negative bloodstream infection: getting to grips with healthcare-associated Escherichia coli bloodstream infection sources.
    Otter JA; Galletly TJ; Davies F; Hitchcock J; Gilchrist MJ; Dyakova E; Mookerjee S; Holmes AH; Brannigan ET
    J Hosp Infect; 2019 Feb; 101(2):129-133. PubMed ID: 30059746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.
    Bergin SP; Thaden JT; Ericson JE; Cross H; Messina J; Clark RH; Fowler VG; Benjamin DK; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Sep; 34(9):933-6. PubMed ID: 26065862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011.
    Williamson DA; Lim A; Wiles S; Roberts SA; Freeman JT
    BMC Infect Dis; 2013 Aug; 13():385. PubMed ID: 23964864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the incidence and 30-day all-cause mortality rate of Escherichia coli bacteraemia in England by 2020/21.
    Bhattacharya A; Nsonwu O; Johnson AP; Hope R
    J Hosp Infect; 2018 Mar; 98(3):228-231. PubMed ID: 28974468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of Escherichia coli causing bloodstream infections in a centralized Canadian region: a population-based surveillance study.
    Holland MS; Nobrega D; Peirano G; Naugler C; Church DL; Pitout JDD
    Clin Microbiol Infect; 2020 Nov; 26(11):1554.e1-1554.e8. PubMed ID: 32120035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
    Aiken AM; Rehman AM; de Kraker MEA; Madrid L; Kebede M; Labi AK; Obeng-Nkrumah N; Nyamwaya B; Kagucia E; Cocker D; Kawaza K; Lester R; Iregbu KC; Medugu N; Nwajiobi-Princewill PI; Dramowski A; Sonda T; Hemed A; Fwoloshi S; Ojok D; Scott JAG; Whitelaw A;
    Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England.
    Abernethy JK; Johnson AP; Guy R; Hinton N; Sheridan EA; Hope RJ
    Clin Microbiol Infect; 2015 Mar; 21(3):251.e1-8. PubMed ID: 25698659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study.
    Laupland KB; Lyytikäinen O; Søgaard M; Kennedy KJ; Knudsen JD; Ostergaard C; Galbraith JC; Valiquette L; Jacobsson G; Collignon P; Schønheyder HC;
    Clin Microbiol Infect; 2013 May; 19(5):465-71. PubMed ID: 22616816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study.
    Mehl A; Åsvold BO; Lydersen S; Paulsen J; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Mar; 17(1):205. PubMed ID: 28284196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique characteristics of community-onset healthcare- associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan.
    Takeshita N; Kawamura I; Kurai H; Araoka H; Yoneyama A; Fujita T; Ainoda Y; Hase R; Hosokawa N; Shimanuki H; Sekiya N; Ohmagari N
    J Hosp Infect; 2017 May; 96(1):29-34. PubMed ID: 28377180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
    Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of community-onset bloodstream infection: a population-based assessment.
    Laupland KB; Gregson DB; Flemons WW; Hawkins D; Ross T; Church DL
    Epidemiol Infect; 2007 Aug; 135(6):1037-42. PubMed ID: 17156500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.